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Primary progressive aphasia (PPA) is characterized by profound destruction of cortical
language areas. Anatomical studies suggest an involvement of cholinergic basal forebrain
(BF) in PPA syndromes, particularly in the area of the nucleus subputaminalis (NSP). Here
we aimed to determine the pattern of atrophy and structural covariance as a proxy of
structural connectivity of BF nuclei in PPA variants. We studied 62 prospectively recruited
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MRIcohort study of the German consortium for frontotemporal lobar degeneration (FTLD). We
determined cortical and BF atrophy based on high-resolution magnetic resonance imaging
(MRI) scans. Patterns of structural covariance of BF with cortical regions were determined
using voxel-based partial least square analysis. We found significant atrophy of total BF
and BF subregions in PPA patients compared with controls [F(1, 82)¼ 20.2, p < .001]. Atrophy
was most pronounced in the NSP and the posterior BF, and most severe in the semantic
variant and the nonfluent variant of PPA. Structural covariance analysis in healthy controls
revealed associations of the BF nuclei, particularly the NSP, with left hemispheric pre-
dominant prefrontal, lateral temporal, and parietal cortical areas, including Broca's speech
area (p < .001, permutation test). In contrast, the PPA patients showed preserved structural
covariance of the BF nuclei mostly with right but not with left hemispheric cortical areas
(p < .001, permutation test). Our findings agree with the neuroanatomically proposed
involvement of the cholinergic BF, particularly the NSP, in PPA syndromes. We found a
shift from a structural covariance of the BF with left hemispheric cortical areas in healthy
aging towards right hemispheric cortical areas in PPA, possibly reflecting a consequence of
the profound and early destruction of cortical language areas in PPA.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In 1892 Arnold Pick first described the syndrome of progres-
sive aphasia in a patient with frontal and temporal lobe at-
rophy at autopsy (Pick, 1892). Almost 100 years later Marsel
Mesulam defined the clinical entity of primary progressive
aphasia (PPA) (Mesulam, 1982) which only recently has been
stratified according to clinical phenomenology into the sub-
types of semantic variant, logopenic variant and nonfluent/
agrammatic aphasia (Gorno-Tempini et al., 2011). The rela-
tionship between the clinical syndromes of PPA and under-
lying neuropathology is not consistent. Tau pathology is most
often found in nonfluent PPA, whereas the semantic variant
frequently presents with Transactive response DNA binding
protein 43 kDa (TDP-43) pathology (Bigio et al., 2010; M.
Mesulam, 2013; Mesulam et al., 2008); Alzheimer's disease is
the underlying pathology in more than 50% of cases with
logopenic variant PPA, but is also found in 15e30% of cases
with other PPA variants (Chare et al., 2014; Harris et al., 2013).
The clinical variants of PPA show distinct patterns of
cortical atrophy (Bisenius, Neumann, & Schroeter, 2016;
Gorno-Tempini et al., 2011; Rogalski et al., 2011; Schroeter,
Raczka, Neumann, & Yves von Cramon, 2007). In addition to
cortical atrophy, subcortical atrophy involving striatal and
thalamic grey matter (GM) has been described in fronto-
temporal lobar degeneration (FTLD), including cases with PPA
(Chow et al., 2008). In Alzheimer's disease (AD), a large body of
evidence suggests early and selective involvement of the
cholinergic system including decline of presynaptic markers
of cholinergic activity in the cortex (Geula, Nagykery,
Nicholas, & Wu, 2008; Henke & Lang, 1983) as well as degen-
eration and loss of cholinergic neurons in the basal forebrain
(BF) nuclei (Baker-Nigh et al., 2015; Boissiere, Faucheux,
Ruberg, Agid, & Hirsch, 1997; Strada et al., 1992; Vana et al.,
2011). The involvement of the cholinergic system in PPA is
still a matter of debate. The notion that a relevant proportionof PPA cases is associated with AD pathology would suggest
involvement of the BF at least in subtypes of PPA. In addition,
neurobiological evidence suggests that a dysbalance of the
temporal lobe cholinergic and the dopaminergic innervation
may play a significant role in language integrity (Tanaka &
Bachman, 2000). Furthermore, Broca's region, the anterior
language area, is characterized by a strong cholinergic inner-
vation (Amunts et al., 2010). The nucleus subputaminalis
(NSP), a cholinergic neuron cluster in the lateral extension of
the Nucleus basalis Meynert, has first been described by Ayala
in 1915 (Ayala, 1915). The nucleus of Ayala has only been
described in humans and anthropoid monkeys, but not in
other species including non-anthropoid primates. The NSP
exhibits a strong left laterality; it is located in close proximity
to the external capsule, suggesting a strong connectivity to the
cortical language areas (Simic et al., 1999). These findings have
raised the question whether the NSP is related to language
function in the human brain.
Together, these findings point to a potential role of the
cholinergic BF in the development of PPA syndromes. However,
this question has only little been studied so far. While cholin-
ergicmarkershavebeenstudiedpostmorteminthebehavioural
variant of FTLD without evidence of major alterations (Procter,
Qurne, & Francis, 1999), we are not aware of a post-mortem
study on cholinergic markers in PPA. In a previous magnetic
resonance imaging (MRI) study in a small sample of 10 patients
with PPA, we showed a significant atrophy of the cholinergic BF
nuclei, including Ayala's nucleus, compared to 18 age-matched
healthy control individuals (Teipel, Flatz, et al., 2014). The
number of participants in this previous study, however, was too
small to allow for a comparison of the pattern of BF atrophy
between subtypes of PPA.
In the present study, we determined the pattern of atrophy
of the cholinergic BF in 62 patients with the diagnosis of PPA
stratified into the clinical variants according to Gorno-
Tempini et al. (2011) in comparison with 31 cognitively
healthy controls. Data were retrieved from a prospective
Table 1 e Participants' demographics.
N
(women)a
Age (SD)
yearsb,c
MMSE (median þ 25th
and 75th percentile)d
Controls 31 (16) 68.2 (8.6) 29 (29, 30)
PPA 62 (32) 65.3 (7.3) 23 (17, 27)
nfvPPA 24 (10) 69.2 (7.0) 23 (20, 26)
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addition, we used a partial least square (PLS) analysis to assess
the pattern of structural covariance as a proxy of structural
connectivity (Alexander-Bloch, Giedd,& Bullmore, 2013) of the
BF in the PPA individuals and controls. The findings would
help us to determine the role of atrophy of the cholinergic BF
in the clinical syndrome of PPA.
lvPPA 9 (6) 64.7 (5.0) 20 (18, 25)
svPPA 18 (8) 61.9 (7.1) 24 (21, 27)
PPAnc 11 (8) 62.8 (6.7) 20 (15, 29)
nfvPPA ¼ nonfluent/agrammatic variant PPA.
lvPPA ¼ logopenic variant PPA.
svPPA ¼ semantic variant PPA.
PPAnc ¼ PPA not further classified.
SD ¼ standard deviation
a Not significantly different between controls and total PPA group
(Chi2 ¼ .0, 1 df, p ¼ 1), and between controls and PPA variants
(Chi2 ¼ 4.1, 4 df, p ¼ .39).
b Not significantly different between controls and total PPA group
(t ¼ 1.7, 91 df, p ¼ .09).
c Significantly different across controls and PPA variants [F(4,
88) ¼ 3.7, p ¼ .008]; with significant difference between controls
and svPPA (t ¼ 2.6, 47 df, p ¼ .012), but no significant difference
between the other PPA variants and controls.
d Significantly different between controls and total PPA group
(ManneWhitney U test, p < .001), and between controls and PPA
variants (ManneWhitney U test, p < .001), but not different be-
tween PPA variants.2. Participants and methods
2.1. Participants
We examined 62 patients with the clinical diagnosis of PPA
[mean age 75.3 (standard deviation 7.3) years, 32 women].
Nine patients were diagnosed as logopenic variant, 24 patient
as nonfluent/agrammatic variant, 18 patients as semantic
variant and 11 patients as PPA not further classified according
to Gorno-Tempini et al. (2011). For comparison, we investi-
gated 31 cognitively healthy elderly subjects [mean age 68.2
(standard aviation 8.6) years, 16 women]. The data of the pa-
tients and controls were retrieved from the cohort of the
German consortium for frontotemporal lobar degeneration
(Otto et al., 2011), funded by the German Federal Ministry of
Research.
PPA patients had undergone an extensive language and
neuropsychological assessment. We applied the Consortium
to Establish a Registry for Alzheimer's Disease (CERAD) plus
battery that includes the Mini-Mental-State Examination
(MMSE) (Folstein, Folstein, & McHugh, 1975), verbal fluency
tasks, naming of line drawings from the Boston Naming Test
as well as verbal and nonverbal delayed recall tasks (Morris
et al., 1989). Further we examined the patients' spontaneous
speech, their ability to describe a picture and applied subtests
of the Aachener Aphasia Examination (Huber, Poeck,Weniger,
& Willmes, 1983) as well as a German version of the Repeat
and Point Task.
In addition, patients were tested using measures of exec-
utive function (e.g., Stroop test, cognitive estimation test) as
well as calculation. The clinical examination also included
tests for buccofacial and ideomotor apraxia and for the
applause sign.
The total PPA group and controls were not significantly
different in age and gender distribution. As expected, PPA
patients had lower performance in the Mini-Mental Status
Examination compared to controls. The demographic char-
acteristics of the PPA patients and controls are summarized in
Table 1.
The assessment of patients and healthy subjects included
detailed medical history and examination, as well as labora-
tory tests (complete blood count, electrolytes, glucose, blood
urea nitrogen, creatinine, liver-associated enzymes, choles-
terol, high density lipoprotein (HDL), triglycerides, serum B12,
folate, thyroid function tests, coagulation, and serum iron).
Ethical approval for conduction of the study has been ob-
tained at the coordinating site at the University of Ulm and all
participating centres of the German consortium for fronto-
temporal lobar degeneration. Written informed consent was
obtained in every case before examination, according to the
declaration of Helsinki.2.2. Cognitive tests
To limit the number of comparisons on the association be-
tween BF volume and cognitive performance, we a priori
selected tests from the comprehensive neuropsychological
battery that are believed to be sustained by cholinergic system
integrity (Bracco, Bessi, Padiglioni, Marini, & Pepeu, 2014):
episodic long term memory (CERAD word list delayed free
recall), verbal fluency (phonematic and semantic fluency), and
executive function (Trail-Making Test e TMT A and B). In
addition, as a control, we selected free figure recall, for which
we expected no association with BF volume.2.3. MRI acquisition
MRI acquisitions of the brain were conducted at 3 T scanners
with parallel imaging capabilities (Siemens Magnetom Trio
and Siemens Magnetom Verio, Siemens Medical Solutions,
Erlangen, Germany). All scanners used a quadrature detection
head coil, where number of channels ranged between 12 and
32 (transmitereceive circularly polarized e CP-head coil).
For the anatomical study, sagittal high-resolution 3-
dimensional gradient-echo sequences were performed (mag-
netisation-prepared rapid gradient-echo (MPRAGE), field-of-
view ranged between 239 and 256 mm, spatial resolution
was .9  .9  1.0  1.0  1.0  1.0 mm3, repetition time ranged
between 6.6 and 2500 msec, echo time ranged between 2.98
and 4.82 msec, inversion time ranged between 500 and
1200 msec, flip angle ranged between 7 and 15, and number
of slices ranged between 160 and 208). To identify white
matter (WM) lesions, coronal 2-dimensional T2-weighted
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covery e FLAIR).
2.4. MRI data processing
The processing of structural MRI scans was implemented
through statistical parametric mapping, SPM8 (Wellcome
Dept. of Imaging Neuroscience, London) and the Voxel based
morphometry (VBM) 8-toolbox (http://dbm.neuro.uni-jena.de/
vbm/) implemented in MATLAB 7.1 (Mathworks, Natwick).
First, images were segmented into GM,WM and cerebrospinal
fluid (CSF) partitions using the tissue prior free segmentation
routine of the VBM8-toolbox. The GM and WM partitions of
each subject were then high-dimensionally registered to a
crisp template of average anatomy in Montreal Neurological
Institute (MNI) space (IXI-template) using the Diffeomorphic
Anatomic Registration using Exponentiated Lie algebra
(DARTEL) algorithm (Ashburner, 2007). The IXI-template is
part of the VBM8-toolbox and was derived by DARTEL inter-
subject alignment of 550 healthy control subjects of the pub-
licly available IXI-Database (http://www.brain-development.
org).
Flow-fields resulting from the DARTEL registration to the
IXI-template were used to warp the GM segments and voxel-
values were modulated for non-linear effects of the high-
dimensional normalization. This preserves the total amount
of GM volume after linear effects of global head size and shape
differences have been accounted for. Finally, modulated
warped GM segments were resliced to an isotropic voxel-size
of 1.5 mm3 and smoothed with a Gaussian smoothing kernel
of 8 mm full-width at half maximum (FWHM) for the analysis
of cortical atrophy and a Gaussian smoothing kernel of 4 mm
for the analysis of BF atrophy. Following the matched-filter
theorem, the optimal smoothing kernel in voxel-based ana-
lyses should be matched in size to the expected effects. The
selection of the different smoothing kernels was based on the
findings of our previous study where changes in the BF were
better detectable in a univariate statistics using 4 mm
smoothing than using 8 mm smoothing (Grothe, Heinsen, &
Teipel, 2013).
2.5. BF mask
The delineation and localization of the cholinergic BF nuclei
according to Mesulam's nomenclature including the localiza-
tion of the NSP in MRI reference space was based on the his-
tological serial coronal sections and post-mortem MRI scan of
a brain from a 56 year old man, as previously described
(Kilimann et al., 2014). In short, subregions of the cholinergic
nuclei were identified from digitalized stained sections of the
BF and manually transferred into the corresponding slices of
the post-mortem MRI of the dehydrated brain in alcohol
space. Employing SPM8 (Wellcome Trust Centre for Neuro-
imaging, London, UK; available at www.fil.ion.ucl.ac.uk/spm)
the MRI brain volume in alcohol space was first transferred
into the post-mortem in cranio MRI space applying a 12-
parameter affine transformation followed by high-dimen-
sional normalization (Ashburner, Andersson, & Friston, 1999).
In a further step, the post-mortem in cranio MRI wastransferred into MNI stereotaxic coordinates standard space
with DARTEL registration method (Ashburner, 2007). The
linear and non-linear transformations from alcohol through
in cranio to MNI space were combined to spatially transform
the BFmask into theMNI standard space.We used thismap to
relate the group effects in local deformations to the anatom-
ical position of the BF nuclei in MNI space.
2.6. Statistical analysis
We used three complementary analysis approaches: (i) uni-
variate voxel-based analysis, (ii) region of interest (ROI) anal-
ysis, and (iii) multivariate PLSs. Of note, all BF volumes have
been adjusted for overall brain size by using only the non-
linear component of the spatial normalization for modula-
tion of GM voxel intensities as described above (Section 2.4).
(i) For the univariate voxel-based analysis we employed
the general linearmodel within the SPM framework.We
determined the between-group differences in GM vol-
ume between the PPA patients and the control subjects
for the GM maps smoothed with an 8 mm kernel, and
for the GM maps smoothed with a 4 mm kernel and
masked for the BF regions, controlling for age, sex and
scanner. For the cortical atrophy analysis, results were
thresholded at p < .05, False discovery rate (FDR) cor-
rected, with a minimum cluster extension threshold of
50 contiguous voxels. The BF results were assessed at a
statistical threshold of p < .05, FDR corrected, with a
minimum cluster extension threshold of five contig-
uous voxels, due to the smaller size of the search region.
(ii) For the ROI analysis, we averaged GM volumes within
each of the subnuclei from the cholinergic BF mask and
compared the average GM volumes between groups
using a multivariate linear model, controlling for age,
sex, and scanner, followed by pairwise post-hoc Scheffe
test between PPA variants and controls. We used partial
correlation for the analysis of the association between
BF volume and cognitive function, controlling for diag-
nosis, age, sex, and scanner.
(iii) To determine the structural covariance of the BF nuclei
we used PLS) analysis (McIntosh & Lobaugh, 2004). This
approach operates on the covariance between brain
voxels and allows assessment of an integrated network
of brain regions that together covarywith some external
measure (Krishnan, Williams, McIntosh, & Abdi, 2011).
Here, we used the GM volumes of the BF nuclei to derive
the principal components from the GM maps. This
approach has also been termed seed voxel analysis
(McIntosh et al., 1999) because GM volume of a specific
location of the brain is regressed on the covariance
structure of the rest of the brain to uncover correlated
networks of structural connectivity. PLS yields a new set
of variables, so called latent variables (LVs) where each
LV identifies a pattern of differences in brain GM be-
tween groups or a pattern of brain regions structurally
connectedwith BF atrophy. Each voxel of the brain has a
weight on each LV, called the salience of this voxel on
the LV. The significance of each LV has been assessed
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p < .05 threshold. In addition, we used bootstrap esti-
mation (with 100 bootstrap iterations) to determine the
reliability of the saliences for the brain voxels deter-
mining each LV. The bootstrap ratios of salience follow
a standard z-score distribution, where a ratio of >1.96
corresponds to a p value of <.05, a ratio of >2.58 to a p
value of <.01. In contrast to univariate analysis, the
permutation tests and the saliences are determined in
one single analytical step so that there is no need for
multiple comparison correction.3. Results
We found significant atrophy of cortical GM in the entire PPA
group compared to controls in left predominant lateral tem-
poral lobe and prefrontal lobe areas, extending into themedial
temporal lobe and frontobasal areas (Supplemental Fig. 1).
The pattern of atrophy in the individuals with PPA not further
classified was focused in prefrontal lobe areas and almost
entirely overlapped with atrophy of the whole PPA group
(Supplemental Fig. 1). Atrophy in the semantic variant was
focused on anterior and lateral temporal lobe of both hemi-
spheres with slight left hemispheric predominance. Atrophy
in the logopenic variant was focused in the prefrontal and
lateral temporal lobe extending into the inferior parietal lobe,
with a strong left hemispheric predominance. Atrophy effects
in the nonfluent/agrammatic variant were focused in the
lateral and anterior temporal lobe and the prefrontal lobe,Fig. 1 e ROI based analysis of BF volumes in PPA variants and co
of brain size adjusted BF subregions and total BF in controls an
(lvPPA), the nonfluent/agrammatic variant (nfvPPA), and the se
further classified (PPAnc). The x-axis shows the BF regions accor
including the entire BF volume (BFtotal). $ e Significantly differe
an ANCOVA model, p < .002. % e Not significantly different bet
ANCOVA model, p ¼ .08. 1 e Significantly different between co
scanner in an ANCOVAmodel, p < .001. 2 e Significantly differen
test, p < .012. 3 e Significantly different between controls and nwith a strong left hemispheric predominance (Supplemental
Fig. 2).
We found a significant atrophy of the brain size adjusted
total BF in all PPA patients compared to healthy controls,
controlling for age, sex, and scanner in the analysis of
covariance (ANCOVA)model, F(1, 82)¼ 20.2, p < .001, as well as
in each PPA subtype {nonfluent/agrammatic variant [F(1,
45) ¼ 7.5, p < .009], logopenic variant [F(1, 29) ¼ 15.5, p < .001],
semantic variant [F(1, 38) ¼ 20.4, p < .001] of PPA, and non-
classified PPA cases [F(1, 31) ¼ 6.3, p < .02]}.
Cohen's d effect size estimates (Cohen, 1988) for total BF
atrophy were .76 in nonfluent/agrammatic variant, .27 in
logopenic variant, 1.21 in semantic variant, and .05 in non-
classified PPA cases.
Using post-hoc Scheffe tests, we found significant atrophy
of BF subnuclei Ch4p and NSP in the nonfluent/agrammatic
and the semantic variant of PPA, respectively (see Fig. 1 for
details). There were no significant differences in total and
regional BF volumes between the PPA variants in a post-hoc
Scheffe test. The voxel-wise distribution of atrophy within
the BF is shown in Fig. 2, comparing the nonfluent/agram-
matic, the logopenic and the semantic variants of PPA with
healthy controls. At a p value of .05, FDR corrected, the PPA
cases not further classified showed no significant decline of
voxel-based GM volume within the BF compared to controls.
When we assessed associations between BF atrophy and
cognitive function, we found no significant effects after con-
trolling for age, sex, scanner and diagnosis (PPA vs controls).
We analyzed the structural covariance of BF volumes using
PLS, controlling for age, sex, scanner, and (in the PPA cases)ntrols. Bar diagram of mean values and standard deviations
d the whole PPA group (PPA total), the logopenic variant
mantic variant of PPA (svPPA), and the cases with PPA not
ding to Mesulam's nomenclature (Mesulam & Geula, 1988),
nt across all groups, controlling for age, sex, and scanner in
ween groups, controlling for age, sex, and scanner in an
ntrols and all PPA patients, controlling for age, sex, and
t between controls and nfvPPA and svPPA, post-hoc Scheffe
fvPPA and svPPA, post-hoc Scheffe test, p < .015.
Fig. 2 e Voxel-based BF atrophy in PPA variants. Coronal sections fromMNI coordinate y¼ 4 to y¼¡12, sections are 1.5 mm
apart. Right of image (R) is right of brain (view from posterior). Clusters of at least five voxels surpassing a significance
threshold of .05, FDR corrected, are shown for the nonfluent/agrammatic variant of PPA (red), the logopenic variant of PPA
(blue), and the semantic variant of PPA (green) compared with controls. Upper left numbers indicate the level of the coronal
section according to the MNI space y-coordinate.
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with left hemispheric predominant lateral temporal, superior
parietal, and prefrontal lobe GM, hippocampus and insular
cortex (Fig. 3). The GM volume in the anterior medial and
anterior lateral region of the BF showed a significant associ-
ation with the cortical GM in bilateral antero-lateral and
antero-medial temporal lobes, left predominant prefrontal
lobe, including Broca's area, and inferior parietal cortex
(Fig. 3). The NSP volume was associated with left hemispheric
predominant lateral temporal cortex, prefrontal lobe,
including Broca's area, superior lateral parietal cortex, hip-
pocampus and insular cortex (Fig. 3). The GM volume in the
posterior region of the BF showed a significant association
with bilateral GM volume of hippocampus and entorhinal
cortex, cingulate gyrus, prefrontal lobe, lateral temporal cor-
tex, and superior parietal lobe (Fig. 3). All effects were signif-
icant at a permuted p value < .001.
In the PPA patients the volume of the total BF showed a
significant association with right hemispheric predominant
GM in the anterior medial frontal lobe, the hippocampus, the
insula cortex and the anterior temporal pole (Fig. 4). The GMvolume in the anterior medial and anterior lateral region of
the BF showed a significant association with the cortical GM
in right hemispheric predominant areas of the frontal and
parietal operculum, the anterior temporal pole, anterior
medial frontal, and medial occipital regions and the hippo-
campus (Fig. 4). The NSP GM volume was significantly
associated with the right hemispheric cortical GM volume in
the insular cortex, the anterior temporal lobe, the hippo-
campus and the head of the caudate nucleus (Fig. 4). The
posterior BF GM volume showed a significant association
with left hemispheric predominance in the cortical GM of
the insular cortex, the anterior temporal lobe, and the hip-
pocampus (Fig. 4). All effects were significant at a permuted
p value < .001.
In a PLS regression analysis of the interaction effect of BF
volume and diagnosis (PPA vs controls), controlling for age,
sex, and scanner, we found a significantly higher covariance
of the total BF volumewith left hemispheric GM volume in the
healthy control cases compared to the PPA cases at p < .001,
including lateral temporal cortex, temporal pole, insular cor-
tex, hippocampus, putamen and inferior frontal gyrus (Fig. 5).
Fig. 3 e Association of BF and cortical GM in controls as determined using PLS analysis. LVs representing brain regions
where cortical GM volume was associated with GM volume of the total BF (upper row, red), the medial and lateral anterior BF
(second row, blue), the NSP (third row, green), and the posterior BF (lower row, cyane), projected on an MRI scan in MNI
standard space. Row four shows the LV for the NSP volume projected onto the rendered surface of an MRI in standard space,
with a red oval in the left hemisphere highlighting the location of Broca's area. Coronal sections go from MNI coordinate
y ¼ 26 to y ¼ ¡46, sections are 9 mm apart. Upper numbers indicate the level of the coronal section according to the MNI
space y-coordinate. Colored voxels represent a significant bootstrap ratio of p < .05. Right of image (R) is right of brain, view
from posterior.
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covariance compared with controls.4. Discussion
We studied atrophy and structural covariance of BF volumes
in a relatively large sample of PPA cases retrieved from a
prospective multicenter cohort study. We found significant
atrophy of total BF volume in PPA cases compared with
healthy control subjects with effects most pronounced in the
posterior BF and the area of the NSP, and most severe in the
nonfluent/agrammatic and the semantic variants of PPA. We
used PLS analysis as a robust and powerful approach to the
assessment of structural covariance and connectivity
(McIntosh & Lobaugh, 2004). The structural covariance of the
total BF andmost of its subregionswas predominant in the left
hemisphere, including prefrontal, lateral temporal and supe-
rior parietal cortical areas in healthy controls, whereas thestructural covariance of the BF regions in the PPA patients was
predominantly located in the right hemisphere, involving
hippocampus, insular cortex, lateral temporal cortex and
anterior temporal pole, and extending into medial frontal and
to some extent into inferior and superior parietal lobule areas.
The pattern of cortical atrophy in PPA and its variants in
our study replicated previous findings in independent studies,
with bilateral involvement of anterior temporal lobes in se-
mantic variant PPA, extension of atrophy into left hemi-
spheric inferior parietal lobe areas in logopenic variant of PPA
and strong involvement of left prefrontal lobe areas in the
nonfluent/agrammatic variant of PPA (Gorno-Tempini et al.,
2004; Rogalski et al., 2011). Different to previous studies, the
parietal lobe areas were not involved in our logopenic variant
cases, but due to the small sample size in this subgroup the
statistical power to detect group differences was limited.
Replicating findings from a previous study in an indepen-
dent small sample of 10 PPA cases and 18 controls (Teipel,
Flatz, et al., 2014), we found significant atrophy of the total
Fig. 4 e Association of BF and cortical GM in PPA as determined using PLS analysis. LVs representing brain regions where
cortical GM volume was associated with GM volume of the total BF (upper row, red), the medial and lateral anterior BF
(second row, blue), the NSP (third row, green), and the posterior BF (lower row, cyane), projected on an MRI scan in MNI
standard space. Coronal sections go from MNI coordinate y ¼ 26 to y ¼ ¡46, sections are 9 mm apart. Upper numbers
indicate the level of the coronal section according to the MNI space y-coordinate. Colored voxels represent a significant
bootstrap ratio of p < .05. Right of image (R) is right of brain, view from posterior.
c o r t e x 8 3 ( 2 0 1 6 ) 1 2 4e1 3 5 131BF in PPA patients. Extending the previous findings, we found
a differential pattern of atrophy between PPA variants. Effects
weremost pronounced in the semantic variant and nonfluent/
agrammatic variant cases with smaller effect sizes in log-
openic variant cases and non-classified PPA cases. Within the
BF, the effects weremost pronounced in themost posterior BF
region (Ch4p) as well as the NSP. Ch4p has consistently been
found to be the most early affected area in dementia due to
Alzheimer's disease as well as in amnestic mild cognitive
impairment (MCI) (Grothe et al., 2013; Teipel, Heinsen, et al.,
2014), considered to represent an at risk stage of Alzheimer's
disease dementia (Petersen et al., 2006). Therefore, one could
speculate that the strong effects in the Ch4p regionmay partly
arise from the underlying Alzheimer's disease pathology in a
subset of the PPA cases. The involvement of the NSP wouldFig. 5 e Interaction of diagnosis by total BF volume on cortical G
regions where the association of cortical GM volume with GM v
controls than in PPA cases, projected on anMRI scan in MNI stan
to y ¼ ¡46, sections are 9 mm apart. Upper numbers indicate th
coordinate. Red voxels represent a significant bootstrap ratio of
posterior.agree with its putative role in language development that has
been pointed out by Simic et al. (1999): the NSP has only been
described in humans and anthropoid monkeys, shows a
strong left laterality, and is located in close proximity to the
external capsule and thus the cortical language areas. Our
findings of a prominent atrophy of this region support a po-
tential involvement of the NSP in PPA. In addition, the pattern
of structural covariance of the BF, particularly the NSP, in the
healthy control subjects included left hemispheric areas, such
as Broca's area, lateral temporal cortex and superior parietal
cortex, including angular gyrus. This pattern of structural
connectivity would agree with an involvement of BF regions,
particularly the NSP, in language function. This association,
however, was not specific for the NSP and requires confir-
mation in longitudinal design to study the onset of regional BFM as determined using PLS analysis. LV representing brain
olume of the total BF was significantly higher in healthy
dard space. Coronal sections go fromMNI coordinate y¼ 26
e level of the coronal section according to the MNI space y-
p < .05. Right of image (R) is right of brain, view from
c o r t e x 8 3 ( 2 0 1 6 ) 1 2 4e1 3 5132atrophy in PPA. In contrast, the posterior BF regions, corre-
sponding to Mesulam's Ch4p, showed more prominent asso-
ciations with medial temporal regions and cingulate gyrus in
the controls, areas that are early involved in Alzheimer's dis-
ease both at autopsy (Braak& Braak, 1991; Price, Davis, Morris,
& White, 1991; Price et al., 2009) and in structural in vivo im-
aging (Baron et al., 2001; Chetelat et al., 2005; Schroeter, Stein,
Maslowski, & Neumann, 2009; Teipel et al., 2006) studies so
that this pattern of connectivity agrees with the early
involvement of the posterior BF region in mild cognitive
impairment and dementia stages of Alzheimer's disease
(Grothe et al., 2013; Teipel, Heinsen, et al., 2014).
When we looked on the pattern of structural covariance of
the NSP (and the other BF regions) in the PPA sample, we
found a right hemispheric predominance of effects, involving
hippocampus, insular cortex, frontobasal areas and lateral
temporal cortex. This pattern does not represent the typical
language areas. This change in pattern of structural covari-
ance from left hemispheric areas involving cortical language
areas in healthy older individuals to right hemispheric regions
involving more posterior and more limbic brain areas in PPA
patients suggests that cortical destruction in PPA destroys the
pattern of structural covariance of BF areas, with relative
preservation of covariance into less affected cortical areas.
This is supported by the results of the interaction analysis.
Here, structural covariance of cortical GM with total BF vol-
ume was significantly higher in healthy controls than in PPA
cases in the left hemisphere. This would also imply that BF
atrophy in PPA may be a secondary event, following primary
left hemispheric cortical destruction in PPA as evidenced by
the partially preserved pattern of covariance in the BF in the
PPA patients with right hemispheric cortical areas. The
interpretation of BF volume as a secondary event in PPA is
further supported by the lack of an association of cognitive
functions with BF volume in our PPA cases. In contrast, in a
recent study on patients with mild cognitive impairment due
to Alzheimer's disease, BF volume was found to correlate with
both memory and executive function deficits (Grothe et al.,
2015). This agrees with the important role of cholinergic
function for executive function and attention as documented
in trials on anticholinergic treatment effects (Dumas &
Newhouse, 2011; Pomara, Nolan, & Halpern, 1995; Snyder
et al., 2014) and the role of cholinergic degeneration as a pri-
mary event in Alzheimer's disease pathogenesis (M.M.
Mesulam, 2013). It is important to note that our interpreta-
tion that the shift in covariance reflects a temporal sequence
of primary cortical and secondary BF atrophy in PPA needs
further replication, and confirmation in a longitudinal design.
The German consortium for frontotemporal lobar degenera-
tion is a still ongoing cohort study so that hopefully in the
upcoming years we will have the data available to determine
whether atrophy in left hemispheric cortical areas indeed
precedes atrophy of the cholinergic BF in early clinical or even
preclinical stages of PPA.
Autopsy data that would help to corroborate the notion of
BF involvement into PPA are still scarce. While cholinergic
markers have been studied post mortem in the behavioural
variant of FTLD without evidence of major alterations (Procter
et al., 1999), we are not aware of a post-mortem study on
cholinergic markers in PPA so far. Another approach tounderstanding the role of cholinergic dysfunction in PPA is
provided by treatment studies using acetylcholinesterase in-
hibitors. Over a short period of eight weeks, galantamine
showed a trend towards stabilization of language function
and global cognition in a small sample of PPA patients
compared to placebo (N ¼ 10 verum, N ¼ 10 placebo) (Kertesz
et al., 2008). An open label study showed improved behav-
ioural symptoms in 20 subjects with the diagnosis of FTLD
treated with rivastigmine compared to 20 untreated FTLD
subjects over 12 months. Part of these effects may be due to
underlying AD pathology in a subset of the patients (Mendez,
2009; Vossel &Miller, 2008). Injecting .4e.6 mg of scopolamine
disrupted cholinergic activity in healthy young women, lead-
ing to impairments in reading, writing, verbal fluency and
object naming (Aarsland, Larsen, Reinvang, & Aasland, 1994).
This further supports the hypothesis that cholinergic deple-
tion affects language.
There are several limitations associated with our study.
First, this is a multicenter study, inducing additional variance
in the volumetricmeasurements. In a previous study, we have
shown that variability of BF measurements is slightly
increased due to a multicenter design (Kilimann et al., 2014).
Here, we used a prospectively harmonized acquisition proto-
col, but had variability in scanner platforms and field
strengths. We accounted for scanner effects in all statistical
models, including the structural covariance analyses. Sec-
ondly, the post-mortem mask of our study is based on only
one single brain. We compared the distribution of our mask
with the distribution of two previous masks, one based on a
single subject (Teipel et al., 2005), and one probabilistic map
based on 10 subjects (Zaborszky et al., 2008). There was a high
general agreement between all three masks, with the only
major difference being that Ch4p was located more ventrally
in the first mask (Teipel et al., 2005) compared to the proba-
bilistic mask (thresholded at 50%) (Zaborszky et al., 2008) and
our mask. These findings suggest that the anatomy of the BF
nuclei is relatively stable across subjects. Thirdly, although
the overall number of PPA cases was relatively large, stratifi-
cation into different variants yielded small subsamples
limiting the statistical power to detect between variant effects
in pattern of BF atrophy. Of particular notion, the effects in the
logopenic variant were unexpectedly small. There were no
significant effects in this variant in the ROI based analysis,
which was, however, not only related to the small number of
nine logopenic variant PPA cases, but also was reflected in the
small effect size for volume differences between the logopenic
variant cases and the healthy controls. Based on the
assumption that the logopenic variant PPA in a considerable
proportion of cases represents an atypical presentation of
Alzheimer's disease one would have expected a particular
involvement of the BF in these individuals. Still, this is the first
study on BF atrophy in logopenic variant PPA so that we
cannot be sure if the language variant of Alzheimer's disease
may even present with an atypically low involvement of BF
areas. Finally, the clinical stratification of PPA cases in
different variants always is amatter of debate. Here, we used a
two-step process of classification in the multicenter design of
the German consortium for frontotemporal lobar degenera-
tion. In the first step, all clinical raters of the consortium
during the recruitment phase of the study underwent
c o r t e x 8 3 ( 2 0 1 6 ) 1 2 4e1 3 5 133regularly scheduled bi-annual rater training in the in-
struments and criteria for clinical classification of fronto-
temporal lobar degeneration, including PPA variants (Otto
et al., 2011). In the second step, all cases that were rated as
low confidence in the classification were rated by an inde-
pendent neuropsychologist based on the neuropsychological
data and the recorded sample of spoken language. In nine out
of 62 cases, such a language sample was not available so that
classification was based on the first step classification only.
The pattern of cortical atrophy in our PPA variants replicates
patterns of cortical atrophy in previous studies so that the
overall classification of individuals seems appropriate
although this does not guarantee correct classification in
every individual case. Classification accuracy is, actually, a
heuristic problem when there is no real gold standard to test
the validity of any classification scheme. Therefore, we oper-
ationalized the process of classification as far as possible in
such a multicenter design.
In summary, we found significant atrophy of the cholin-
ergic BF in PPA cases compared with healthy older control
individuals. Effects weremost prominent in the posterior area
of the BF and in the area of the NSP. The structural covariance
pattern of the BF nuclei, particularly the NSP, in the healthy
control individuals agree with an involvement of the BF in
language function. The pattern of structural covariance of the
BF in PPA cases compared with controls suggests a shift of
covariance from left anterior to more right posterior brain
areas from healthy aging to PPA, possibly as a consequence of
the profound destruction of the cortical language areas in PPA.
Our findingswould agreewith the assumption that BF atrophy
is a secondary event, after earlier destruction of cortical lan-
guage areas, in PPA, but this hypothesis needs further
confirmation in longitudinal data.Acknowledgements
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